Nadège Pelletier
Chief Tech/Sci/R&D Officer bij BARINTHUS BIOTHERAPEUTICS PLC
Vermogen: - $ op 31-03-2024
Profiel
Nadège Pelletier is currently the Chief Scientific Officer at Barinthus Biotherapeutics Plc.
Prior to this, she worked as a Senior Principal Scientist at Novartis Institutes for Biomedical Research, Inc. She holds a doctorate degree from Université Claude Bernard Lyon 1 and a graduate degree from École Normale Supérieure de Lyon.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Nadège Pelletier
| Bedrijven | Functie | Begin |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01-02-2023 |
Eerdere bekende functies van Nadège Pelletier
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Nadège Pelletier
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| École Normale Supérieure de Lyon | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Vaccitech Plc |
